DISCLAIMER: This product is strictly for research use only. It is meant solely for laboratory testing and in vitro studies-not for use in or on humans or animals. All details provided on this site are for educational purposes. It is illegal to introduce this substance into the body. Only licensed professionals should handle it. This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such.
CJC-1295 (No DAC) + GHRP-6 (Blend)
CJC-1295 (no DAC) and GHRP-6 work through separate pathways to boost natural growth hormone release, potentially enhancing recovery and appetite.
Quantity: 1
All peptides arrive in powdered form for stability
Third-Party Verified Purity
Each batch is tested and certified to meet or exceed 99% purity standards.
Made in the USA
Produced in United States WHO/GMP and ISO 9001:2015 certified facilities.
Rigorous Quality Control
Double-tested to ensure the highest quality for the most effective research.
What is CJC-1295 (No DAC) + GHRP-6 (Blend)?
CJC-1295 without Drug Affinity Complex (no DAC) is a short-acting synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to release GH in a pulsatile, physiologic pattern. GHRP-6 (Growth Hormone Releasing Peptide-6) is a hexapeptide growth hormone secretagogue that activates the ghrelin receptor to trigger GH release through a separate pathway. GHRP-6 is also known for stimulating appetite via ghrelin-mimicking effects. When combined, these peptides may amplify GH output and recovery potential by targeting two independent GH stimulation pathways.
Potential Benefits Shown in Studies
Possible benefits of CJC‑1295 (No DAC) + GHRP‑6 Blend
- Amplified GH Release
- Enhanced Muscle Growth & Recovery
- Improved Fat Metabolism
- Natural GH Rhythm Preservation
- Support for Anti‑Aging & Sleep
Mechanisms of Action
CJC-1295 (no DAC) + GHRP-6 may work together by:
- CJC-1295 (no DAC): Activating GHRH receptors for short bursts of natural GH release
- GHRP-6: Triggering ghrelin receptors for additional GH release and appetite stimulation
- Increasing IGF-1 to support muscle repair, connective tissue healing, and collagen synthesis
- Potentially enhancing metabolism and recovery capacity in research settings
- Producing synergistic GH output by combining GHRH and ghrelin receptor activation
Molecular Structure of Blend Components
CJC-1295 (No DAC) Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser
Molecular Properties
CJC-1295 (No DAC) + GHRP-6 (Blend) Research Highlights
Combining CJC‑1295 (No DAC) with GHRP‑6 leverages two independent hormonal pathways, leading to amplified GH release through dual receptor engagement.
Source: muscleandbrawn
Blending a GHRH analog (CJC‑1295 no DAC) with a GHS like GHRP‑6 activates separate receptors to potentiate growth hormone release.
Source: peptidereport
CJC‑1295 (No DAC) mimics natural GH pulses without receptor desensitization risk, thanks to its short half-life.
Source: pep-pedia
CJC‑1295 without DAC is a short-acting analog of GHRH that reproduces the body’s natural growth hormone (GH) pulse patterns, with a half-life of around 30 minutes.
Source: pep-pedia
Its short duration allows for frequent administration that avoids pituitary down-regulation—a key advantage for maintaining physiologic GH sensitivity.
Source: hkroids
Used in conjunction with GHRP peptides like Ipamorelin, CJC‑1295 (no DAC) can enhance GH pulse amplitude and stimulate downstream IGF‑1 signaling for anabolic effects.
Source: thepeptidereport
Clinical and preclinical studies have linked CJC‑1295 (general notes across versions) to increases in GH/IGF‑1, improvements in body composition, sleep, and anti-aging markers—though human data remains limited for No DAC specifically.
Source: peptideinstitute
GHRP‑6, a synthetic hexapeptide, is known for its high potency in stimulating growth hormone (GH) secretion via the ghrelin receptor, distinguishing it from GHRH-based pathways.
Source: springer
In rat models, GHRP‑6 administered alongside doxorubicin prevented heart failure and multi-organ damage, boosting antioxidant defenses, preserving mitochondrial integrity, and reducing fibrosis.
Source: frontiers
Studies show that central administration of GHRP‑6 in rats triggers feeding behavior, activating hypothalamic and brainstem regions—even when animals had no access to food.
Source: academic
